Investors & Media

홈Investors & MediaNews release

News release

News VasThera receives FDA Orphan Drug Designation for Pulmonary Arterial Hypertension Drug Candidate
2024-11-27

VasThera receives FDA Orphan Drug Designation for Pulmonary Arterial Hypertension Drug Candidate

View more
News [K-Biotech to conquer dementia] ③ Vasthera CEO Sang Won Kang
2024-07-12

[K-Biotech to conquer dementia] ③ Vasthera CEO Sang Won Kang

View more
Investors VasThera to Attend BIO-Europe 2023
2023-11-29

VasThera to Attend BIO-Europe 2023

View more
Investors VasThera to Attend Bio Japan 2023
2023-10-20

VasThera to Attend Bio Japan 2023

View more
News VasThera won the Prize of Minister (Ministry of SMEs and Startups)
2023-01-03

VasThera won the Prize of Minister (Ministry of SMEs and Startups)

View more
News Dr. Sang Won Kang attended a business exchange meeting at the Korea Biotech Industry Organization
2022-10-27

Dr. Sang Won Kang attended a business exchange meeting at the Korea Biotech Industry Organization

View more
Investors VasThera’s Dr. Sang Won Kang to Present at the 2022 BIO International Convention
2022-06-14

VasThera’s Dr. Sang Won Kang to Present at the 2022 BIO International Convention

View more
TOPTOP
검색 닫기